IQ-AI Share Price (IQAI)

Paladin

Thank you for the great post. It is frustrating how we have not had anything official from the company about the phase 1, the scheduled FDA meeting and possible phase 2 partners. We seem to be in a period of “radio silence”. TB will probably tweet about the primary completion in a few days judging on past events.

I totally agree on Mike and the team. We couldn’t ask for a more dedicated group who seem to always be meeting their targets.

Who knows we may get a surprise RNS about the trial or the imaging side and your 25p price will be far exceeded.

Let’s see what happens.

Good luck and have a great weekend everybody

Thanks

Firstly, my thanks to all contributors on this forum for the updates on the GaM Ph1 trial, and IB’s product development. The cogs are grinding slowly and in the absence of significant news, the share price remains grounded in the 1.30 - 1.40p range.

Two days ago, my dummy sells showed that it was only possible to sell even a tiny volume of IQAI shares by negotiated trades. My understanding of this is that the broker will attempt to achieve the best possible price for the shares. This implies that recent sells were achieved in this way?

This morning, it was possible to sell up to 60,000 shares directly, but at 1.302p per share. During the day, my broker’s indicative price is 1.343p per share. The reverts to the LSE price (currently 1.4p) at the close of trading.

I am puzzled at the lack of interest in IB, having thoroughly researched all the recent updates? However, I hope that the status quo will remain into the start of the next financial year. This will enable me to transfer funds into my ISA, where my IQ-AI shares are based, and buy a few more. I will then achieve my limit.

I am very careful in my investments nowadays, having lost a considerable amount of capital in a biopharmaceutical company in which the CEO and all the major decision makers achieved nothing whatsoever in three years, leading to dilution and delisting. Hopefully, we won’t be subjected to similar incompetence here? That having been said, I remain optimistic about IQ-AI’s future possibilities. I have no idea regarding a realistic valuation for the company should the Ph1 trial, and the company’s innovative technologies achieve their potential? Currently, 25p per share would cancel my losses in the aforementioned company, which was manned by a less than competent team. At least, I have no such concerns about IB, in which everyone seem to be working hard and achieving good outcomes. GLA.

Thanks Shrek

So phase 1 primary has been competed was completed in February. I assume the October date is completion of all the paperwork. Let’s hope we get an update from Mike about partners for phase 2

Thank you

Primary completion 13/02/2025

Forever cryptic , still recruiting but completed ?? Any ideas

Thanks Shrek